Yi Kui Li
Fortuna: 14 M $ al 31/05/2026
Fortuna: 14 M $ al 31/05/2026
Yi Kui Li served as Chairman of Tonghua Dongbao Pharmaceutical Co., Ltd. from 2010 to 2019.
He also worked as Director at Xiamen Amoytop Biotech Co. Ltd. from 2018 to 2020.
Mr. Li obtained his undergraduate degree from Peking University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2025 | 11.328.579 ( 0,57 % ) | 14 M $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| XIAMEN AMOYTOP BIOTECH CO., LTD. | Director/Miembro de la Junta | 11/06/2020 |
| TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. | Presidente | 03/03/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonghua Dongbao Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells insulin raw material medicines, preparations and diabetes related medical devices | Health Technology |
Xiamen Amoytop Biotech Co. Ltd.
Xiamen Amoytop Biotech Co. Ltd. BiotechnologyHealth Technology Provides research and development services for recombinant protein drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.